Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal pain upper	Gastrointestinal disorders	Valbenazine	5	85
other	Nausea	Gastrointestinal disorders	Valbenazine	9	85
other	Fatigue	General disorders	Valbenazine	11	85
other	Irritability	General disorders	Valbenazine	8	85
other	Headache	Nervous system disorders	Valbenazine	9	85
other	Sedation	Nervous system disorders	Valbenazine	10	85
other	Somnolence	Nervous system disorders	Valbenazine	17	85
other	Depression	Psychiatric disorders	Valbenazine	5	85
serious	Infected bites	Infections and infestations	Valbenazine	1	85
serious	Cognitive disorder	Nervous system disorders	Valbenazine	1	85
serious	Henoch-Schonlein purpura	Skin and subcutaneous tissue disorders	Valbenazine	1	85

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03444038/events